MedTrace Logo

PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia

NCT06294782 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-03-06

No results posted yet for this study

Summary

This is a multicenter, interventional study. The study will enroll patients that fulfill the inclusion criteria over a 33-month period. Considering the small number of patients who will meet the study criteria, it is also possible to include retrospective patients who already underwent STAR (for instance, as part of a compassionate program) if they meet all the inclusion and exclusion criteria as well as the treatment planning standardized requirements and sign their consent to this trial. All patients prospectively enrolled will undergo a flow of investigations following a standardized approach. ICD programming will be standardized.

Conditions

  • Refractory Ventricular Tachycardia

Interventions

RADIATION

STereotactic Arhythmia Radioablation (STAR)

STereotactic Arhythmia Radioablation (STAR)

Sponsors & Collaborators

  • Azienda USL Reggio Emilia - IRCCS

    collaborator OTHER_GOV

  • IRCCS Sacro Cuore Don Calabria di Negrar

    collaborator OTHER

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER

  • University of Turin, Italy

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06294782 on ClinicalTrials.gov